What is blood cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Blood Cancer?

Blood cancer is a group of malignant diseases that originate from cells in the blood, bone marrow, or lymphatic system, characterized by abnormal cell growth that disrupts normal blood cell production and immune function. 1, 2

Major Categories of Blood Cancer

Blood cancers are divided into three primary types, each affecting different components of the hematopoietic system:

Leukemia

  • Malignancy that starts in blood-forming tissues, especially the bone marrow, characterized by clonal expansion of abnormal blood cells 1
  • Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults and accounts for the largest number of annual deaths from leukemias in the United States 1
  • Includes subtypes such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia 1

Lymphoma

  • Cancer affecting the lymphatic system, which is part of the body's immune network 2
  • Includes Hodgkin lymphoma and non-Hodgkin lymphoma as major subtypes 1, 3
  • Non-Hodgkin lymphoma incidence is rapidly increasing in some regions, particularly in association with HIV infection 3

Multiple Myeloma

  • Malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure 1
  • Accounts for approximately 1.8% of all cancers and slightly more than 15% of hematologic malignancies in the United States 1
  • Characterized by production of monoclonal immunoglobulin, causing skeletal damage, hypercalcemia, renal insufficiency, anemia, and infections 1

Additional Blood Cancer Categories

Myelodysplastic Syndromes (MDS)

  • Borderline conditions that can progress to acute leukemia 2
  • Often grouped with myeloproliferative neoplasms in classification systems 1

Myeloproliferative Neoplasms (MPNs)

  • Include chronic neutrophilic leukemia, chronic eosinophilic leukemia, and other rare subtypes 1
  • Represent a heterogeneous group with varying clinical manifestations and prognoses 1

Key Distinguishing Feature

Blood cancers are classified as "liquid tumors" because the cancer is present in body fluids (blood, lymph, bone marrow) rather than forming solid masses. 4 This fundamental characteristic distinguishes them from solid organ cancers and affects both their behavior and treatment approaches 4.

Clinical Impact

  • Blood cancers account for approximately 9.6% of new cancer diagnoses in the United States, with an estimated 184,130 new cases annually 1
  • These malignancies represent the fifth most common cancer in some countries, with approximately 38,000 people diagnosed yearly in Britain 2
  • The median age at diagnosis varies by type, with AML having a median age of 67-71 years, while multiple myeloma has a median age of 69 years 1

Interconnected Nature

Because blood, bone marrow, and lymph nodes are naturally connected through the immune system, a disease affecting one tissue will often affect the others as well. 2, 5 This interconnection explains why blood cancers frequently present with systemic manifestations rather than localized disease 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Haematological cancers.

Nursing standard (Royal College of Nursing (Great Britain) : 1987), 2016

Research

Targeted Drug Delivery for the Treatment of Blood Cancers.

Molecules (Basel, Switzerland), 2022

Research

An approach for leukemia classification based on cooperative game theory.

Analytical cellular pathology (Amsterdam), 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.